Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Proscar in Men With Initial Negative Prostate Biopsies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Diagnostic, Treatment
Approved-not yet active
18 and over
Pharmaceutical / Industry
2007_029
MK0906-143, NCT00547079
2.
Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of The Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Approved-not yet active
18 and over
Pharmaceutical / Industry
2007_028
MK0906-144, NCT00547430
Last Modified:
12/8/2008
 
First Published:
2/16/2007
3.
Phase II Randomized Study of Neoadjuvant Finasteride in Patients With Stage II Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
Adult
NCI
MDA-03-1-03
MDA-2006-0614, MDA03-1-03, NCT00438464
Last Modified:
8/29/2008
 
First Published:
8/14/2008
4.
Phase II Randomized Study of Selenomethionine and Finasteride Prior to Prostatectomy in Patients With Stage I or II Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
RPCI-I-104607
I 104607, NCT00736645
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute